Tuesday afternoon's analyst upgrades and downgrades included CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and more.
A couple of Cathie Wood's ARK Invest exchange-traded funds bought over 675,000 shares of CRISPR Therapeutics on October 14.
A couple of Cathie Wood's ARK Invest exchange-traded funds bought over 400,000 shares of CRISPR Therapeutics on October 10.
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.
The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.
The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.
The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Monday’s top analyst upgrades and downgrades included Chipotle Mexican Grill, CRISPR, Hess Midstream, iMedia Brands, Kinder Morgan, Wendy’s and more.
Wednesday's top analyst upgrades and downgrades included AutoZone, Citrix Systems, Coinbase, CSX, Freeport-McMoRan, Intuitive Surgical, Morgan Stanley, Netflix and Oracle.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Anthem, BioMarin, CRISPR, GE and more.
Thursday's top analyst upgrades and downgrades included Allstate, Bed Bath & Beyond, Simon Property, Spirit Airlines, Twitter and Under Armour.
Thursday's top analyst upgrades and downgrades included Best Buy, Booking, ConocoPhillips, CRISPR Therapeutics, Fisker, Halliburton, Lordstown Motors, RH, Tesla, Walt Disney and Zscaler.
Monday's top analyst upgrades and downgrades included Accenture, Boeing, CRISPR Therapeutics, DraftKings, Illumina, Lyft, McDonald's, Southwest Airlines and Teladoc Health.
